What is Dabigatran Etexilate 150 mg?
Dabigatran Etexilate 150 mg is an oral anticoagulant medication primarily used to prevent the formation of harmful blood clots. It is widely prescribed for patients at risk of stroke, deep vein thrombosis (DVT), and pulmonary embolism. Manufactured by Boehringer Ingelheim India Pvt.Ltd, this medicine has established efficacy and safety profiles suitable for long-term blood clot prevention management.
This medication is particularly valuable for patients with atrial fibrillation who require preventive treatment to lower their risk of stroke. Due to its targeted functioning, Dabigatran Etexilate 150 mg is an important option within modern anticoagulation therapy, offering an effective alternative to traditional blood thinners.
Uses of Dabigatran Etexilate 150 mg
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
- Treatment and prevention of deep vein thrombosis (DVT)
- Prevention of pulmonary embolism after initial treatment
- Reduction in the risk of recurrent blood clots
- Used post-orthopedic surgery to reduce clot risk
How Dabigatran Etexilate 150 mg Works
Dabigatran Etexilate is a direct thrombin inhibitor. It works by selectively blocking thrombin (factor IIa), an essential enzyme in the blood coagulation process. By inhibiting thrombin, this medicine prevents the conversion of fibrinogen to fibrin, the protein that forms the structural basis of a blood clot.
This inhibition effectively reduces the ability of blood platelets to clump together, preventing new clots from forming and existing clots from growing. Because it's administered orally and has predictable pharmacological effects, Dabigatran Etexilate offers convenient and reliable anticoagulation therapy.
Benefits of Dabigatran Etexilate 150 mg
- No need for frequent blood monitoring, unlike some traditional anticoagulants
- Reduced risk of intracranial hemorrhage compared to warfarin
- Rapid onset of action providing timely protection against clotting
- Fixed dosing simplifies patient compliance
- Effective in preventing stroke and embolism in atrial fibrillation patients
Dosage and Administration
The usual recommended dose is 150 mg taken twice daily, with or without food. It is important to swallow the capsules whole with water and not to crush or chew them. Consistency in timing is essential, so taking the medication at the same times each day is advised to maintain stable blood levels.
Dosage adjustments may be necessary for patients with renal impairment or increased bleeding risk. Always consult a healthcare professional before starting or modifying the dose.
Who Should Use Dabigatran Etexilate 150 mg?
Dabigatran Etexilate 150 mg is suitable for adults who need anticoagulation therapy to prevent stroke, embolism, or venous thromboembolism. This includes patients with:
- Non-valvular atrial fibrillation at risk of stroke
- Recent hip or knee replacement surgery
- A history of deep vein thrombosis or pulmonary embolism requiring long-term management
Who Should Avoid Dabigatran Etexilate 150 mg?
The medication is not recommended for individuals with:
- Active pathological bleeding
- Severe kidney impairment or on dialysis
- Mechanical prosthetic heart valves
- Hypersensitivity to Dabigatran or its excipients
- Conditions with a high risk of bleeding like recent brain injury
Side Effects
- Bleeding, including nosebleeds and gums bleeding
- Easy bruising or prolonged bleeding from cuts
- Gastrointestinal discomfort such as indigestion or stomach pain
- Nausea
- Anemia (low red blood cell count)
- Allergic reactions like rash or itching
- Fatigue or weakness
Safety Advice
- Inform your doctor about any history of bleeding disorders
- Notify healthcare providers before any surgery or dental procedures
- Avoid medications that increase bleeding risk without consulting your doctor
- Report any unusual or prolonged bleeding immediately
- Do not stop taking the medication without medical advice
- Store medication away from moisture and heat
Drug Interactions
- Other anticoagulants such as warfarin or heparin
- Antiplatelet agents including aspirin and clopidogrel
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Certain antifungal and antiviral medications
- Drugs that affect kidney function
Storage Instructions
Store Dabigatran Etexilate 150 mg capsules in a cool, dry place away from direct sunlight. Keep the medication in its original blister pack until use to protect it from moisture. Keep out of reach of children. Do not use the medication past the expiration date printed on the packaging.
Where to buy Dabigatran Etexilate 150 mg in Canada?
If you are looking to buy Dabigatran Etexilate 150 mg in Canada, it can be obtained through licensed pharmacies with a valid prescription. It is important to purchase from reputable sources to ensure product authenticity and safety. Additionally, some certified online Canadian pharmacies offer safe purchasing options with professional consultation available.
Frequently Asked Questions (FAQ)
Is Dabigatran Etexilate 150 mg available in Canada?
Yes, Dabigatran Etexilate 150 mg is available in Canada with a valid prescription from licensed pharmacies.
What is the price of Dabigatran Etexilate 150 mg in Canada?
The price varies based on pharmacy and insurance coverage; consulting with local pharmacies or healthcare providers is advised for current pricing.
What happens if I miss a dose?
If you miss a dose, take it as soon as you remember on the same day. Do not double the dose the next time.
Where can I find Dabigatran Etexilate 150 mg for sale?
You can find it at licensed Canadian pharmacies or certified online pharmacy platforms with prescription verification.
Can I take Dabigatran Etexilate 150 mg with other medications?
It may interact with certain medications; consult your healthcare provider before combining with other drugs.
How should I store Dabigatran Etexilate 150 mg?
Store in a cool, dry place away from moisture and heat, and keep out of reach of children.
Is it safe to drink alcohol while taking Dabigatran Etexilate 150 mg?
Alcohol can increase bleeding risk; moderate to avoid excessive consumption and consult your doctor.
Conclusion
Dabigatran Etexilate 150 mg is a reliable and effective anticoagulant medication designed to prevent blood clots and reduce the risk of stroke and embolism. Manufactured by Boehringer Ingelheim India Pvt.Ltd, it offers benefits such as fixed dosing and fewer monitoring requirements compared to traditional blood thinners. Patients in Canada seeking a safe and convenient option to manage clotting risk are encouraged to consult healthcare professionals about this proven treatment.
Leave A Review